Added in April 2024 3 April UPDATE – Q&A on Pharmacovigilance Legislation NEW – Procedural advice on Zero Day MR Procedures NEW – Minutes of the Meeting of a subgroup of CMDh with Interested Parties dedicated to LoSC and publication of PI updates NEW – Art. 46 PAR on Verorab (Rabies virus, inactivated) NEW – Art. 46 PAR on Triptorelin (Decapeptyl, Diphereline, Arvekap) UPDATE – List of active substances for which data has been submitted in accordance with Article 45 of the Paediatric Regulation
